Business Description
The Hydration Pharmaceuticals Co Ltd
ISIN : AU0000187957
Compare
Compare
Traded in other countries / regions
HPC.Australia IPO Date
2021-12-14Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.65 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -28.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50 | |||||
3-Year EBITDA Growth Rate | 50.9 | |||||
3-Year EPS without NRI Growth Rate | 51.1 | |||||
3-Year FCF Growth Rate | 45.4 | |||||
3-Year Book Growth Rate | -47.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.09 | |||||
9-Day RSI | 42.21 | |||||
14-Day RSI | 47.52 | |||||
12-1 Month Momentum % | -66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.83 | |||||
Quick Ratio | 1.7 | |||||
Cash Ratio | 1.45 | |||||
Days Inventory | 293.14 | |||||
Days Sales Outstanding | 31.2 | |||||
Days Payable | 115.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.6 | |||||
Shareholder Yield % | -45.09 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.13 | |||||
Operating Margin % | -127.11 | |||||
Net Margin % | -115.57 | |||||
EBITDA Margin % | -111.28 | |||||
FCF Margin % | -147.51 | |||||
OCF Margin % | -147.51 | |||||
ROE % | -141.64 | |||||
ROA % | -85.93 | |||||
ROIC % | -561.38 | |||||
3-Year ROIIC % | -262.57 | |||||
ROC (Joel Greenblatt) % | -777.28 | |||||
ROCE % | -135.56 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.44 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 0.4 | |||||
EV-to-EBIT | -1.41 | |||||
EV-to-EBITDA | -1.41 | |||||
EV-to-Revenue | 1.57 | |||||
EV-to-FCF | -1.16 | |||||
Earnings Yield (Greenblatt) % | -70.77 | |||||
FCF Yield % | -257.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
The Hydration Pharmaceuticals Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 3.751 | ||
| EPS (TTM) (A$) | -0.011 | ||
| Beta | 1.3029 | ||
| 3-Year Sharpe Ratio | -0.99 | ||
| 3-Year Sortino Ratio | -1.25 | ||
| Volatility % | 50.42 | ||
| 14-Day RSI | 47.52 | ||
| 14-Day ATR (A$) | 0.000236 | ||
| 20-Day SMA (A$) | 0.00415 | ||
| 12-1 Month Momentum % | -66.67 | ||
| 52-Week Range (A$) | 0.003 - 0.019 | ||
| Shares Outstanding (Mil) | 537.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
The Hydration Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
The Hydration Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
The Hydration Pharmaceuticals Co Ltd Frequently Asked Questions
What is The Hydration Pharmaceuticals Co Ltd(ASX:HPC)'s stock price today?
The current price of ASX:HPC is A$0.00. The 52 week high of ASX:HPC is A$0.02 and 52 week low is A$0.00.
When is next earnings date of The Hydration Pharmaceuticals Co Ltd(ASX:HPC)?
The next earnings date of The Hydration Pharmaceuticals Co Ltd(ASX:HPC) is .
Does The Hydration Pharmaceuticals Co Ltd(ASX:HPC) pay dividends? If so, how much?
The Hydration Pharmaceuticals Co Ltd(ASX:HPC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on The Hydration Pharmaceuticals Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers